Mohammed Hussein Mohammed

Dr. Mohammed Hussein Mohammed


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2023 in Pathophysiology
Verified
Journal Article
Open access
PDF file
MEMagdy Y. Elsaeed
Magdy Y. Elsaeed
Osama Mahmoud MehannaOsama Mahmoud Mehanna
Osama Mahmoud Mehanna
EAEzz-Eldin E. Abd-Allah
Ezz-Eldin E. Abd-Allah
MHMohamed Gaber Hassan
Mohamed Gaber Hassan
WAWalid Mostafa Ahmed
Walid Mostafa Ahmed
MMMohammed Hussein Mohammed
Mohammed Hussein Mohammed
Background: As the impacts of diabetes-induced reproductive damage are now evident in young people, we are now in urgent need to devise new ways to protect and enhance the reproductive health of diabetic people. The present study aimed to evaluate the protective effects of enalapril (an ACE inhibitor) and paricalcitol (a vitamin D analog), individually or in combination, on streptozotocin (STZ)-diabetes-induced testicular dysfunction in rats and to identify the possible mechanisms for this protection. Material and methods: This study was carried out on 50 male Sprague-Dawley rats; 10 normal rats were allocated as a non-diabetic control group. A total of 40 rats developed diabetes after receiving a single dose of STZ; then, the diabetic rats were divided into four groups of equivalent numbers assigned as diabetic control, enalapril-treated, paricalcitol-treated, and combined enalapril-and-paricalcitol-treated groups. The effects of mono and combined therapy with paricalcitol and enalapril on testicular functions, sperm activity, glycemic state oxidative stress, and inflammatory parameters, as well as histopathological examinations, were assessed in comparison with the normal and diabetic control rats. Results: As a result of diabetes induction, epididymal sperm count, sperm motility, serum levels of testosterone, follicle-stimulating hormone (FSH) as well as luteinizing hormone (LH), and the antioxidant enzyme activities, were significantly decreased, while abnormal sperm (%), insulin resistance, nitric oxide (NO), malondialdehyde (MDA), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) were significantly increased, along with severe distortion of the testicular structure. Interestingly, treatment with paricalcitol and enalapril, either alone or in combination, significantly improved the sperm parameters, increased antioxidant enzyme activities in addition to serum levels of testosterone, FSH, and LH, reduced insulin resistance, IL-6, and TNF-α levels, and finally ameliorated the diabetes-induced testicular oxidative stress and histopathological damage, with somewhat superior effect for paricalcitol monotherapy and combined therapy with both drugs compared to monotherapy with enalapril alone. Conclusions: Monotherapy with paricalcitol and its combination therapy with enalapril has a somewhat superior effect in improving diabetes-induced testicular dysfunction (most probably as a result of their hypoglycemic, antioxidant, anti-inflammatory, and anti-apoptotic properties) compared with monotherapy with enalapril alone in male rats, recommending a synergistic impact of both drugs.
1

18 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
MEMagdy Y. Elsaeed
Magdy Y. Elsaeed
OMOsama Mahmoud Mehanna
Osama Mahmoud Mehanna
EAEzz-Eldin El-Sharkawy Abd-Allah
Ezz-Eldin El-Sharkawy Abd-Allah
MHMohamed G. M. Hassan
Mohamed G. M. Hassan
WAWalid Mostafa Ahmed
Walid Mostafa Ahmed
MMMohammed Hussein Mohammed
Mohammed Hussein Mohammed
Background: As the impacts of diabetes-induced reproductive damage are now evident in young people, we are now in an urgent need to devise new ways to protect and enhance the reproductive health of diabetic people. The purpose of this study was to assess the protective impact of enalapril (an ACE inhibitor) and paricalcitol (a vitamin D analogue) alone and in combination, on streptozotocin (STZ) diabetes-induced testicular dysfunction in rats. Material and methods: This study was carried on 50 male Sprague-Dawley rats; 10 normal rats were allocated as non-diabetic control group. 40 rats developed diabetes after receiving a single dose of STZ, then the diabetic rats were divided into four groups of equivalent number assigned as diabetic control, enalapril treated, paricalcitol treated, in addition to combined enalapril and paricalcitol treated groups. The effects of mono and combined therapy with paricalcitol and enalapril on testicular functions, sperm activity, glycemic state oxidative stress and inflammatory parameters as well as histopathological examination were assessed when compared to the normal and diabetic control rats. Results: As a result of diabetes induction, epididymal sperm count, sperm motility, serum levels of testosterone, follicle stimulating hormone (FSH) as well as luteinizing hormone (LH) and the antioxidant enzyme activities were significantly decreased, while abnormal sperm (%), insulin resistance, nitric oxide (NO), malondialdehyde (MDA), interleukin-6 (IL-6) as well as tumor necrosis factor-α (TNF-α) were significantly increased, along with sever distortion of testicular structure. Interestingly, treatment with paricalcitol and enalapril either alone or in combination significantly improved the sperm parameters, increased antioxidant enzyme activities in addition to serum levels of testosterone, FSH and LH, reduced insulin resistance, IL-6 and TNF-α levels and finally ameliorated the diabetes-induced testicular oxidative stress and histopathological damage with somewhat superior effect for paricalcitol monotherapy and combined therapy with both drugs than monotherapy with enalapril alone. Conclusion: Monotherapy with paricalcitol and its combination therapy with enalapril has a somewhat superior effect in improving the diabetes-induced testicular dysfunction (most probably as a result of their hypoglycemic, antioxidant, anti-inflammatory and anti-apoptotic properties), than monotherapy with enalapril alone in male rats, recommending a synergistic impact of both drugs.
1

2 February 2020 in Al-Azhar International Medical Journal
Verified
Journal Article
Closed access
PDF file
MMMohammed Hussein Mohammed
Mohammed Hussein Mohammed
MAMohammed Mokhtar Amin El Assaly
Mohammed Mokhtar Amin El Assaly
HAHamdino Mohamed Attia
Hamdino Mohamed Attia
Background: Aging is a gradual deterioration in the function of tissues and organ systems with loss of the ability to maintain homeostasis, due to structural alteration or dysfunction. Aging impact directly on all the different types of liver cells: hepatocytes, liver sinusoidal endothelial cells (LSECs), Küpffer cells (KCs) and hepatic stellate cells (HSCs). Activation of HSCs leads to deposition of collagen in the space of Disse, decrease of fenestrations of LSECs and formation of basement membrane. These changes called pseudocapillarization. Tenascin-C (TN-C) is an extracellular matrix glycoprotein markedly up-regulated during liver fibrosis. Tenascin-C is highly expressed during embryonic development, wound healing, chronic inflammation and cancer. Aim of the study: we investigated the contribution of TNC to liver pseudocapillarization by comparing expression of tenascin c and levels of fibrosis deposition in space of Disse in different age groups. Material and methods: Different ages of albino rats ( 6, 12, 18, 24, 30 and 36 months ) were chosen and sacrificed. Morphometric and serological parameters were assessed and the liver samples were processed for histological and immunohistochemical staining. Results: Immunohistochemical staining revealed a gradual increase in TNC deposition from first to forth group then gradual decrease occurred. Masson’s stain revealed gradual increase of fibrosis in space of Disse deposition from 2nd to 6th group. Conclusion: TNC appear and increase before appearance of fibrosis but when fibrosis is formed TNC is down regulated again.